Abstract:The pathogenesis of idiopathic Parkinson's disease is unknown, but nigral degeneration and depigmentation are associated with microglial inflammation and anti-inflammatory medications appear to protect against the disease. The possibility that humoral immunity may play a role in initiating or regulating the inflammation has been suggested by experimental studies triggering dopamine cell death using a variety of transfer strategies and the observation of CD8+ T lymphocytes and complement in the nigra in Parkinson's disease. We analysed the association between degeneration and humoral immune markers in brain tissue of patients with idiopathic (n = 13) or genetic (n = 2 with alpha-synuclein and n = 1 with parkin mutations) Parkinson's disease and controls without neurological disease (n = 12) to determine the humoral immune involvement in Parkinson's disease. Formalin-fixed tissue samples from the substantia nigra and primary visual cortex for comparison were stained for alpha-synuclein, major histocompatibility complex II (HLA), immunoglobulin M (IgM), immunoglobulin G (IgG), IgG subclasses 1-4 and IgG receptors FcgammaR I-III. Antigen retrieval and both single immunoperoxidase and double immunofluorescence procedures were employed to determine the cell types involved and their pattern and semiquantitative densities. Significant dopamine neuron loss occurred in all patients with Parkinson's disease, negatively correlating with disease duration (r = -0.76, P = 0.002). Although all patients had increased inflammatory HLA immunopositive microglia, the degree of inflammation was similar throughout the disease (r = 0.08, P = 0.82). All patients with Parkinson's disease had IgG binding on dopamine neurons but not IgM binding. Lewy bodies were strongly immunolabelled with IgG. A mean 30 +/- 12% of dopamine nigral neurons were immunoreactive for IgG in Parkinson's disease with the proportion of IgG immunopositive neurons negatively correlating with the degree of cell loss in the substantia nigra (r = -0.67, P < 0.0001) and positively correlating with the number of HLA immunopositive microglia (r = 0.51, P = 0.01). Most neuronal IgG was the IgG1 subclass with some IgG3 and less IgG2 also found in the damaged substantia nigra. The high affinity activating IgG receptor, FcgammaRI, was expressed on nearby activated microglia. The low affinity activating IgG receptor, FcgammaRIII was expressed on cells morphologically resembling lymphocytes, whereas immunoreactivity for the inhibitory IgG receptor FcgammaRII was absent in all cases. This pattern of humoral immune reactivity is consistent with an immune activation of microglia leading to the targeting of dopamine nigral neurons for destruction in both idiopathic and genetic cases of Parkinson's disease.

Relevance of tissue-resident memory CD8 T cells in the onset of Parkinson's disease and examination of its possible etiologies: infectious or autoimmune?

CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's disease

Cytokine and Chemokine Map of Peripheral Specific Immune Cell Subsets in Parkinson's Disease

Single-cell transcriptome and TCR profiling reveal activated and expanded T cell populations in Parkinson’s disease

The Role of Immune Dysfunction in Parkinson's Disease Development

The immune system in Parkinson's disease: what we know so far

The spatial landscape of glial pathology and T-cell response in Parkinson’s disease substantia nigra

Integrative Analyses of Single-Cell Transcriptome and Immune Profiling Reveal Clonal Expansion of T Cells in the Blood and Cerebrospinal Fluid of Parkinson's Disease

A possible role for humoral immunity in the pathogenesis of Parkinson's disease

The role of the CD8+ T cell compartment in ageing and neurodegenerative disorders

The Pathogenesis of Parkinson's Disease: A Complex Interplay Between Astrocytes, Microglia, and T Lymphocytes?

Early-to-mid idiopathic Parkinson’s disease shows a more cytotoxic but declined CD8-regulatory peripheral immune profile

Unaltered T cell responses to common antigens in individuals with Parkinson's disease

The Role of T Cells in the Pathogenesis of Parkinson's Disease

Periphery and brain, innate and adaptive immunity in Parkinson's disease

The systemic immune response in Parkinson's disease: focus on the peripheral immune component

Specific immune status in Parkinson’s disease at different ages of onset

Neuroinflammation is associated with infiltration of T cells in Lewy body disease and α-synuclein transgenic models

The Challenge of the Pathogenesis of Parkinson's Disease: Is Autoimmunity the Culprit?

The Role of Enteric Glial Cells and Their Involvement in the Pathogenesis of Parkinson's Disease

The Innate and Adaptive Immune Cells in Alzheimer's and Parkinson's Diseases